Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen

Abstract

A global vaccination strategy must take into account production and delivery costs as well as efficacy and safety. A heat-stable, polyvalent vaccine that requires only one inoculation and induces a high level of humoral and cellular immunity against several diseases is therefore desirable. A new approach is to use live microorganisms such as mycobacteria1, enteric bacteria2,3, adenoviruses4, herpes viruses5,6 and poxviruses7 as vaccine vectors. A potential limitation of live polyvalent vaccines, however, is existing immunity within the target population not only to the vector, but to any of the expressed antigens. This could restrict replication of the vector, curtail expression of antigens, and reduce the total immune response to the vaccine. Recently acquired immunity to vaccinia virus can severely limit the efficacy of a live recombinant vaccinia-based vaccine8, so a strategy involving closely spaced inoculations with the same vector expressing different antigens may present difficulties. We have constructed a recombinant vaccinia virus that expresses surface proteins from two diverse pathogens, influenza A virus haemagglutinin and herpes simplex virus type 1 (HSV-1) glycoprotein D. Mice that had recently recovered from infection with either HSV-1 or influenza A virus could still be effectively immunized with the double recombinant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Jacobs, W. R., Tuckman, M. & Bloom, B. R. Nature 327, 532–535 (1987).

    Article  ADS  CAS  Google Scholar 

  2. Clements, J. D. & El-Morshidy, S. Infect. Immunity 46, 564–569 (1984).

    CAS  Google Scholar 

  3. Baron, L. S. et al. Infect. Immunity 55, 2797–2801 (1987).

    CAS  Google Scholar 

  4. Davis, A. R. et al. Proc. natn. Acad. Sci. U.S.A. 82, 7560–7564 (1985).

    Article  ADS  CAS  Google Scholar 

  5. Shih, M.-F., Arsenakis, M., Tiollais, P. & Roizman, B. Proc. natn. Acad. Sci. U.S.A. 81, 5867–5870 (1984).

    Article  ADS  CAS  Google Scholar 

  6. Lowe, R. S. et al. Proc. natn. Acad. Sci. U.S.A. 84, 3896–3900 (1987).

    Article  ADS  CAS  Google Scholar 

  7. Moss, B. & Flexner, C. A. Rev. Immun. 5, 305–324 (1987).

    Article  CAS  Google Scholar 

  8. Rooney, J., Wohlenberg, C., Cremer, K., Moss, B. & Notkins, A. L. J. Virol 62, 1530–1534 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Panicali, D., Davis, S. W., Weinberg, R. L. & Paoletti, E. Proc. natn. Acad. Sci. U.S.A. 80, 5364–5368 (1983).

    Article  ADS  CAS  Google Scholar 

  10. Smith, G. L., Murphy, B. R. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 80, 7155–7159 (1983).

    Article  ADS  CAS  Google Scholar 

  11. Andrew, M. E., Coupar, B. E. H., Ada, G. L. & Boyle, D. B. Microbial Pathogenesis 1, 443–452 (1986).

    Article  CAS  Google Scholar 

  12. Paoletti, E., Lipinskas, B. R., Samsonoff, C., Mercer, S. & Panicali, D. Proc. natn. Acad. Sci U.S.A. 81, 193–197 (1984).

    Article  ADS  CAS  Google Scholar 

  13. Cremer, K. J., Mackett, M., Wohlenberg, C., Notkins, A. L. & Moss, B. Science 228, 737–740 (1985).

    Article  ADS  CAS  Google Scholar 

  14. Perkus, M. E., Piccini, A., Lipinskas, B. R. & Paoletti, E. Science 229, 981–984 (1985).

    Article  ADS  CAS  Google Scholar 

  15. Bennink, J. R., Yewdell, J. W., Smith, G. L. & Moss, B. J. Virol. 57, 786–791 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Chakrabarti, S., Brechling, K. & Moss, B. Molec. cell Biol. 5, 3403–3409 (1985).

    Article  CAS  Google Scholar 

  17. Murphy, B. R. et al. J. clin. Microbiol. 13, 554–560 (1981).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. McKendall, R. & Woo, W. J. gen. Virol. 69, 847–857 (1988).

    Article  CAS  Google Scholar 

  19. Rector, J., Lausch, R. & Oakes, J. Infect. Immunity 55, 2797–2801 (1987).

    Google Scholar 

  20. Fenner, F. in Virology (eds Fields, B. N. et al.) 661–684 (Raven, New York, 1985).

    Google Scholar 

  21. Flexner, C., Hugin, A. & Moss, B. Nature 330, 259–262 (1987).

    Article  ADS  CAS  Google Scholar 

  22. Mackett, M., Smith, G. L. & Moss, B. in DNA Cloning Vol. 2 (ed. Glover, D. M.) 191–212 (1RL, Oxford, 1985).

    Google Scholar 

  23. Massicot, J. G. et al. Virology 101, 242–249 (1980).

    Article  CAS  Google Scholar 

  24. Nerurkar, L. S. et al. J. clin. Microbiol. 20, 109–114 (1984).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Buller, R. M. L., Bhatt, P. N. & Wallace, G. D. J. clin. Microbiol. 18, 1220–1225 (1983).

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flexner, C., Murphy, B., Rooney, J. et al. Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen. Nature 335, 259–262 (1988). https://doi.org/10.1038/335259a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/335259a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing